Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health

Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability in young adults. It has effects at different levels: physical, emotional, psychological, cognitive and social, with a great variety of signs and symptoms. In particular, spasticity contributes to reducing the m...

Full description

Bibliographic Details
Main Authors: Silvia Ciotti, Mary Micheli, Antonella Cometa, Claudia De Carlo, Giancarlo Martini, Andrea Marona, Laura Filippetti, Diego Carducci, Silvano Baratta, Mauro Zampolini, Francesco Corea
Format: Article
Language:English
Published: SMC MEDIA SRL 2021-10-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/2298
_version_ 1818883489155514368
author Silvia Ciotti
Mary Micheli
Antonella Cometa
Claudia De Carlo
Giancarlo Martini
Andrea Marona
Laura Filippetti
Diego Carducci
Silvano Baratta
Mauro Zampolini
Francesco Corea
author_facet Silvia Ciotti
Mary Micheli
Antonella Cometa
Claudia De Carlo
Giancarlo Martini
Andrea Marona
Laura Filippetti
Diego Carducci
Silvano Baratta
Mauro Zampolini
Francesco Corea
author_sort Silvia Ciotti
collection DOAJ
description Multiple sclerosis (MS) is the most common cause of non-traumatic neurological disability in young adults. It has effects at different levels: physical, emotional, psychological, cognitive and social, with a great variety of signs and symptoms. In particular, spasticity contributes to reducing the motor performance of patients with MS, causing pain, reduction in distance walked and limitations in social life. We present the case of a 39-year-old woman with MS. She was treated with delta-9-tetrahydrocannabinol/cannabidiol and the outcome was assessed with the International Classification of Functioning Disability and Health core set framework.
first_indexed 2024-12-19T15:34:28Z
format Article
id doaj.art-eefb9eb4af6f476d932ac8b39d05ecec
institution Directory Open Access Journal
issn 2284-2594
language English
last_indexed 2024-12-19T15:34:28Z
publishDate 2021-10-01
publisher SMC MEDIA SRL
record_format Article
series European Journal of Case Reports in Internal Medicine
spelling doaj.art-eefb9eb4af6f476d932ac8b39d05ecec2022-12-21T20:15:39ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942021-10-0110.12890/2021_0022981914Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and HealthSilvia Ciotti0Mary Micheli1Antonella Cometa2Claudia De Carlo3Giancarlo Martini4Andrea Marona5Laura Filippetti6Diego Carducci7Silvano Baratta8Mauro Zampolini9Francesco Corea10 USL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation, S.M. Stella, Orvieto, ItalyUSL Umbria 2, Department of Rehabilitation, Domus Gratiae, Terni, ItalyUSL Umbria 2, Department of Rehabilitation, Ospedale di Cascia, Cascia, ItalyDepartment of Neuroradiology, USL Umbria 2, Ospedale S.G. Battista, Foligno, ItalyUSL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, Italy USL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista, Foligno, Italy USL Umbria 2, Department of Rehabilitation, S.C.R.I.N. Trevi, ItalyUSL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista, Foligno, Italy USL Umbria 2, Department of Rehabilitation and Neurology, Ospedale S.G. Battista, Foligno, ItalyMultiple sclerosis (MS) is the most common cause of non-traumatic neurological disability in young adults. It has effects at different levels: physical, emotional, psychological, cognitive and social, with a great variety of signs and symptoms. In particular, spasticity contributes to reducing the motor performance of patients with MS, causing pain, reduction in distance walked and limitations in social life. We present the case of a 39-year-old woman with MS. She was treated with delta-9-tetrahydrocannabinol/cannabidiol and the outcome was assessed with the International Classification of Functioning Disability and Health core set framework.https://www.ejcrim.com/index.php/EJCRIM/article/view/2298multiple sclerosisicfneurorehabilitationdelta-9-tetrahydrocannabinol/cannabidiol
spellingShingle Silvia Ciotti
Mary Micheli
Antonella Cometa
Claudia De Carlo
Giancarlo Martini
Andrea Marona
Laura Filippetti
Diego Carducci
Silvano Baratta
Mauro Zampolini
Francesco Corea
Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health
European Journal of Case Reports in Internal Medicine
multiple sclerosis
icf
neurorehabilitation
delta-9-tetrahydrocannabinol/cannabidiol
title Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health
title_full Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health
title_fullStr Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health
title_full_unstemmed Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health
title_short Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health
title_sort treatment with delta 9 tetrahydrocannabinol cannabidiol in multiple sclerosis influence on the autonomy profile according to the international classification of functioning disability and health
topic multiple sclerosis
icf
neurorehabilitation
delta-9-tetrahydrocannabinol/cannabidiol
url https://www.ejcrim.com/index.php/EJCRIM/article/view/2298
work_keys_str_mv AT silviaciotti treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth
AT marymicheli treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth
AT antonellacometa treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth
AT claudiadecarlo treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth
AT giancarlomartini treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth
AT andreamarona treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth
AT laurafilippetti treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth
AT diegocarducci treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth
AT silvanobaratta treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth
AT maurozampolini treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth
AT francescocorea treatmentwithdelta9tetrahydrocannabinolcannabidiolinmultiplesclerosisinfluenceontheautonomyprofileaccordingtotheinternationalclassificationoffunctioningdisabilityandhealth